Who Paid My Doc
Sin Lee
Clinical Pathology/Laboratory Medicine Milford, CT
NPI 1679533236 CMS profile 980599
300 Seaside Ave, Milford, CT 06460
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Sin Lee of Milford, CT.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Other Clinical Pathology/Laboratory Medicine in Connecticut
Sheldon Campbell
Clinical Pathology/Laboratory Medicine · New Haven, CT
Henry Rinder
Clinical Pathology/Laboratory Medicine · New Haven, CT
Mark Shlomchik
Clinical Pathology/Laboratory Medicine · New Haven, CT
Wade Schulz
Clinical Pathology/Laboratory Medicine · New Haven, CT
Thomas Durant
Clinical Pathology/Laboratory Medicine · New Haven, CT
Diane Krause
Clinical Pathology/Laboratory Medicine · New Haven, CT
Related records
Clinical Pathology/Laboratory Medicine in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Pathology/Laboratory Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.